Home Journals Articles Updates About
CN
image
收藏切换
Incentive policy evaluation on orphan drugs in the United States during 1983—2019
收藏切换
Jing-shu YANG1, 2, 3, Dian-zheng YANG1, 4, Yue YANG1, 2
Chinese Journal of New Drugs | 2021, 30(21) : 1921 - 1927
Less
收藏切换
Chinese Journal of New Drugs | 2021, 30(21): 1921-1927
Incentive policy evaluation on orphan drugs in the United States during 1983—2019
Full
Jing-shu YANG1, 2, 3, Dian-zheng YANG1, 4, Yue YANG1, 2
Affiliations
  • 1School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China
  • 2Key Laboratory of Innovative Drug Research and Evaluation, National Medical Products Administration, Beijing 100084, China
  • 3Tsinghua-Peking Center for Life Sciences, Tsinghua University, Beijing 100084, China
  • 4School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China
Published: 2021-11-15
Outline
收藏切换

The incentive policy for orphan drugs was evaluated by statistical analysis of the R&D (research and development) and approval of orphan drugs in the United States during 1983—2019. The clinical trials funding, qualification and approval of orphan drugs were statistically analyzed by consulting the FDA official website, clinicaltrial.gov database and related literature. Since the implementation of the Orphan Drug Act in 1983, the United States has established a systematic R&D incentive system for orphan drugs up to now, which has played a huge role in promoting drug R&D and approval.

rare disease  /  orphan drug  /  research and development  /  review and approval  /  clinical trials
杨景舒, 杨殿政, 杨悦. 1983—2019年美国孤儿药激励政策评价. 中国新药杂志, 2021 , 30 (21) : 1921 -1927 .
Jing-shu YANG, Dian-zheng YANG, Yue YANG. Incentive policy evaluation on orphan drugs in the United States during 1983—2019[J]. Chinese Journal of New Drugs, 2021 , 30 (21) : 1921 -1927 .
Appendix
Less
Year 2021 volume 30 Issue 21
23
3
Cite this Article
BibTeX
Article Info
  • Online Date：2026-10-30
  • Published：2021-11-15
Article Data
Affiliations
History
  • Accepted：2021-02-20
Affiliations
    1School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China
    2Key Laboratory of Innovative Drug Research and Evaluation, National Medical Products Administration, Beijing 100084, China
    3Tsinghua-Peking Center for Life Sciences, Tsinghua University, Beijing 100084, China
    4School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family		 属数
Number of
genus		 种数
Number of
species		 占总种数比例
Percentage of
total species (%)		 属
Genus		 种数
Number of
species		 占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT
Links
Articles
Latest Articles
Most Read
Collections
Updates
Events
News
Multimedia
About
About Us
Contact
No. 86 Xueyuan South Road, Haidian District, Beijing
100081
010-62662699(Operation and Technical Support)
qkjq@cast.org.cn

Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House